Clinical Radiology
Volume 61, Issue 8 , Pages 670-678 , August 2006

Chemotherapy-induced sclerosing cholangitis

  • K. Sandrasegaran

      Affiliations

    • Department of Radiology
    • Corresponding Author InformationGuarantor and correspondent: K. Sandrasegaran, Indiana University Medical Center, 550 N. University Blvd, Suite UH0279, Indianapolis, IN 46202, USA. Tel.: +1 317 274 1837; fax: +1 317 274 1848.
    • ,
  • W.M. Alazmi

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • ,
  • M. Tann

      Affiliations

    • Department of Radiology
    • ,
  • E.L. Fogel

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • ,
  • L. McHenry

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • ,
  • G.A. Lehman

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA

Received 29 November 2005 ,Revised 19 January 2006 ,Accepted 28 February 2006.

References 

  1. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039–2048
  2. Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg. 1998;228:756–762
  3. Kerr DJ, McArdle CS, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet. 2003;361:368–373
  4. Martin JK, O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 1990;125:1022–1027
  5. Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer. 2001;30:147–160
  6. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000;18:243–254
  7. Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg. 2004;188:714–721
  8. Anderson SD, Holley HC, Berland LL, et al. Causes of jaundice during hepatic artery infusion chemotherapy. Radiology. 1986;161:439–442
  9. Shea WJ, Demas BE, Goldberg HI, et al. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation. AJR Am J Roentgenol. 1986;146:717–721
  10. Batts KP. Ischemic cholangitis. Mayo Clin Proc. 1998;73:380–385
  11. Ludwig J, Kim CH, Wiesner RH, et al. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?. Hepatology. 1989;9:215–218
  12. Northover JM, Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg. 1979;66:379–384
  13. Aldrighetti L, Arru M, Ronzoni M, et al. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Hepatogastroenterology. 2001;48:1302–1307
  14. Botet JF, Watson RC, Kemeny N, et al. Cholangitis complicating intraarterial chemotherapy in liver metastasis. Radiology. 1985;156:335–337
  15. Pozniak MA, Babel SG, Trump DL. Complications of hepatic arterial infusion chemotherapy. RadioGraphics. 1991;11:67–79
  16. Clark RA, Gallant TE. Bile duct strictures associated with hepatic arterial infusion chemotherapy. Gastrointest Radiol. 1987;12:148–151
  17. Pien EH, Zeman RK, Benjamin SB, et al. Iatrogenic sclerosing cholangitis following hepatic arterial chemotherapy infusion. Radiology. 1985;156:329–330
  18. Chartrand-Lefebvre C, Dufresne MP, Lafortune M, et al. Iatrogenic injury to the bile duct: a working classification for radiologists. Radiology. 1994;193:523–526
  19. Hohn D, Melnick J, Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol. 1985;3:98–102
  20. Nemec P, Ondrasek J, Studenik P, et al. Biliary complications in liver transplantation. Ann Transplant. 2001;6:24–28
  21. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology. 1993;17:605–609
  22. Kasper HU, Dries V, Drebber U, et al. Florid ischemic cholangitis due to leucocytoclastic vasculitis. J Gastroenterol. 2004;39:188–191
  23. Viola S, Meyer M, Fabre M, et al. Ischemic necrosis of bile ducts complicating Schonlein-Henoch purpura. Gastroenterology. 1999;117:211–214
  24. Baluyut AR, Sherman S, Lehman GA, et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc. 2001;53:308–312
  25. Bader TR, Braga L, Beavers KL, et al. MR imaging findings of infectious cholangitis. Magn Reson Imaging. 2001;19:781–788
  26. Ito K, Mitchell DG, Outwater EK, et al. Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol. 1999;172:1527–1533
  27. Kanematsu M, Danet MI, Leonardou P, et al. Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. J Magn Reson Imaging. 2004;20:242–249
  28. Bjornsson E, Chapman RW. Sclerosing cholangitis. Curr Opin Gastroenterol. 2003;19:270–275
  29. Mancuso A, Giuliani R, Accettura C, et al. Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. Anticancer Res. 2003;23:1917–1922
  30. Hasegawa K, Kubota K, Aoki T, et al. Ischemic cholangitis caused by transcatheter hepatic arterial chemoembolization 10 months after resection of the extrahepatic bile duct. Cardiovasc Intervent Radiol. 2000;23:304–306

PII: S0009-9260(06)00132-2

doi: 10.1016/j.crad.2006.02.013

Clinical Radiology
Volume 61, Issue 8 , Pages 670-678 , August 2006

Article Tools

* Image Usage & Resolution